6-K 1 gsk.htm RESULT OF AGM gsk

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
 
 
For the month of May 2024
 
Commission File Number 001-15170
 
 
GSK plc
(Translation of registrant's name into English)
 
 
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive office)
 
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
 
 
 
 
 GSK plc
 
Results of 24th Annual General Meeting
 
GSK plc ('GSK') held a hybrid Annual General Meeting ('AGM') at 2.30pm on Wednesday 8 May 2024 at the Royal Lancaster London, Lancaster Terrace, London, W2 2TY. Shareholders were able to join the meeting in person or virtually via the Lumi AGM website.
 
All valid proxy votes (whether submitted electronically or in hard copy form) were included in the poll taken at the meeting.
 
The table below shows the results of the poll on all 23 resolutions. The full text of the resolutions is contained in the Notice of AGM published on 25 March 2024, which is available on GSK's website at www.gsk.com.
 
Resolution
Total votes for(1)(2)
%
Total votes against(2)
%
Total votes cast
Votes withheld(3)
 
1
Receive and adopt the 2023 Annual Report
3,026,657,634
99.93
1,985,899
0.07
3,028,643,533
11,560,313
2
Approve the Annual report on remuneration 
2,782,337,600
92.70
219,140,461
7.30
3,001,478,061
38,693,019
3
Election of Wendy Becker
2,908,153,080
95.87
125,392,399
4.13
3,033,545,479
6,609,293
4
Election od Dr Jeannie Lee
3,029,569,885
99.87
4,058,143
0.13
3,033,628,028
6,567,803
5
Re-election of Sir Jonathan Symonds
3,018,694,064
99.51
14,982,162
0.49
3,033,676,226
6,516,614
6
Re-election of Dame Emma Walmsley
3,028,232,685
99.81
5,822,706
0.19
3,034,055,391
6,142,099
7
Re-election of Julie Brown
3,024,167,039
99.68
9,628,961
0.32
3,033,796,000
6,386,918
8
Re-election of Elizabeth McKee Anderson
2,960,185,482
97.57
73,605,787
2.43
3,033,791,269
6,404,117
9
Re-election of Charles Bancroft
3,019,529,985
99.54
13,986,857
0.46
3,033,516,842
6,668,927
10
Re-election of Dr Hal Barron
3,022,032,114
99.61
11,790,927
0.39
3,033,823,041
6,360,307
11
Re-election of Dr Anne Beal
3,021,808,961
99.60
12,038,342
0.40
3,033,847,303
6,336,638
12
Re-election of Dr Harry C Dietz
3,029,031,724
99.85
4,650,326
0.15
3,033,682,050
6,508,974
13
Re-election of Dr Jesse Goodman
3,028,663,561
99.84
4,930,361
0.16
3,033,593,922
6,598,956
14
Re-election of Dr Vishal Sikka
2,868,354,507
94.57
164,801,089
5.43
3,033,155,596
7,017,053
15
Re-appointment of the auditor
3,014,623,759
99.95
1,608,077
0.05
3,016,231,836
23,950,717
16
Remuneration of the auditor
3,031,902,105
99.92
2,552,472
0.08
3,034,454,577
5,710,703
17
Authority for the company to make donations to political organisations and incur political expenditure
2,932,886,023
98.76
36,920,830
1.24
2,969,806,853
70,418,813
18
Authority to allot shares
2,902,088,897
95.68
130,945,918
4.32
3,033,034,815
7,163,455
19
Disapplication of pre-emption rights - general power(4)
2,961,493,840
97.71
69,555,193
2.29
3,031,049,033
9,105,429
20
Disapplication of pre-emption rights - in connection with an acquisition or specified capital investment(4)
2,937,510,909
96.91
93,802,022
3.09
3,031,312,931
8,843,231
21
Authority for the company to purchase its own shares(4)
3,007,905,874
99.25
22,735,155
0.75
3,030,641,029
9,526,430
22
Exemption from statement of senior statutory auditor's name
2,960,435,195
99.72
8,381,561
0.28
2,968,816,756
71,372,939
23
Authority for reduced notice of a general meeting other than an AGM(4)
2,795,236,350
93.79
185,233,215
6.21
2,980,469,565
59,729,307
 
 
Notes:
 
(1)
The "for" votes include those giving the Chair discretion.
(2)
Votes "for" and "against" are expressed as a percentage of the total votes cast.
(3)
A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of votes "for" or "against" a resolution.
(4)
Indicates Special Resolutions requiring a 75% majority of votes cast.
 
The Company's issued share capital as at 3 May 2024 consisted of 4,144,937,355 shares of 31 ΒΌ pence each ('Ordinary Shares') excluding Ordinary Shares held in Treasury. Every shareholder has one vote for every Ordinary Share held.
 
The above poll results will shortly be available on the company's website at www.gsk.com.
 
In accordance with Listing Rule 9.6.2 of the Financial Conduct Authority's (FCA) Listing Rules, a copy of the resolutions, other than those concerning ordinary business, will be submitted to the FCA and will in due course be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
 
 
V A Whyte
Company Secretary
8 May 2024
 
 
 
 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
GSK plc
 
(Registrant)
 
 
Date: May 8, 2024
 
 
 
 
By:/s/ VICTORIA WHYTE
--------------------------
 
 
 
Victoria Whyte
 
Authorised Signatory for and on
 
behalf of GSK plc